Geneoscopy
Developer of a molecular diagnostic platform designed to prevent, detect, and monitor gastrointestinal diseases through noninvasive testing. The company's platform offers stool-derived eukaryotic RNA ...
Valuation
$440M
Market implied
Share Price
N/A
Total Raised
$218.4M
Last Round
N/A